6 investors discuss why AI is more than just a buzzword in biotech
TechCrunch
DECEMBER 15, 2022
As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. VCs are also increasingly looking for what biotech startups can do with AI beyond just R&D and are wary of companies that use the technology as a marketing tool. The survey also covers the implications of U.S
Let's personalize your content